Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2011

Open Access 01-01-2011 | Original Article

Formal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable Populations

Authors: Miranda Surjadi, Cara Torruellas, Claudia Ayala, Hal F. Yee Jr., Mandana Khalili

Published in: Digestive Diseases and Sciences | Issue 1/2011

Login to get access

Abstract

Background

Hepatitis C (HCV) knowledge is limited in injection drug users (IDU). Vulnerable populations including IDUs are disproportionally affected by HCV. Effective HCV education can potentially reduce disparity in HCV prevalence and its outcome in this population.

Aim

This study aimed to assess the impact of formal HCV education and factors associated with improved HCV knowledge in the vulnerable population.

Methods

Over 18 months, 201 HCV-infected patients underwent a 2-h standardized education and completed demographic and pre- and post-education questionnaires.

Results

Patient characteristics were: 69% male, mean age 49 ± 10, 49% White (26% AA, 10% Latino), 75% unemployed, 83% high school education and above, 64% were IDU, and 7% were HIV co-infected. On multivariate analysis, baseline knowledge scores were higher in patients with at least a high school education (coef 7.1, p = 0.045). Baseline knowledge scores were lower in African Americans (coef −12.3, p = 0.004) and older patients (coef −0.7, p = 0.03). Following HCV education, the overall test scores improved significantly by 14% (p = 0.0001) specifically in the areas of HCV transmission (p = 0.003), general knowledge (p = 0.02), and health care maintenance (p = 0.004). There was a high compliance with liver specialty clinic attendance following education.

Conclusions

Formal HCV education is effective in improving HCV knowledge. Although White race, younger age, and higher education were predictors of having more HCV knowledge prior to education, all patients independent of racial background had a significant improvement in their knowledge after education. Therefore, promoting effective HCV education among vulnerable populations may be an important factor in reducing the disparities in HCV disease.
Literature
1.
go back to reference Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–714.PubMed Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–714.PubMed
2.
go back to reference Fabris P, Tositti G, Giordani MT, et al. Assessing patients’ understanding of hepatitis C virus infection and its impact on their lifestyle. Aliment Pharmacol Ther. 2006;23:1161–1170.CrossRefPubMed Fabris P, Tositti G, Giordani MT, et al. Assessing patients’ understanding of hepatitis C virus infection and its impact on their lifestyle. Aliment Pharmacol Ther. 2006;23:1161–1170.CrossRefPubMed
3.
go back to reference Minuk GY, Gutkin A, Wong SG, Kaita KD. Patient concerns regarding chronic hepatitis C infections. J Viral Hepat. 2005;12:51–57.CrossRefPubMed Minuk GY, Gutkin A, Wong SG, Kaita KD. Patient concerns regarding chronic hepatitis C infections. J Viral Hepat. 2005;12:51–57.CrossRefPubMed
4.
go back to reference Munoz-Plaza CE, Strauss S, Astone-Twerell J, et al. Exploring drug users’ attitudes and decisions regarding hepatitis C (HCV) treatment in the US. Int J Drug Policy. 2008;19:71–78.CrossRefPubMed Munoz-Plaza CE, Strauss S, Astone-Twerell J, et al. Exploring drug users’ attitudes and decisions regarding hepatitis C (HCV) treatment in the US. Int J Drug Policy. 2008;19:71–78.CrossRefPubMed
5.
go back to reference Strauss E. Barriers to care of chronic hepatitis patients in Latin America. Arch Med Res. 2007;38:711–715.CrossRefPubMed Strauss E. Barriers to care of chronic hepatitis patients in Latin America. Arch Med Res. 2007;38:711–715.CrossRefPubMed
6.
go back to reference Strauss SM, Falkin GP, Vassilev Z, Des Jarlais DC, Astone J. A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat. 2002;22:55–62.CrossRefPubMed Strauss SM, Falkin GP, Vassilev Z, Des Jarlais DC, Astone J. A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat. 2002;22:55–62.CrossRefPubMed
7.
go back to reference Walley AY, White MC, Kushel MB, Song YS, Tulsky JP. Knowledge of and interest in hepatitis C treatment at a methadone clinic. J Subst Abuse Treat. 2005;28:181–187.CrossRefPubMed Walley AY, White MC, Kushel MB, Song YS, Tulsky JP. Knowledge of and interest in hepatitis C treatment at a methadone clinic. J Subst Abuse Treat. 2005;28:181–187.CrossRefPubMed
8.
go back to reference Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse. 1999;34:727–746.CrossRefPubMed Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse. 1999;34:727–746.CrossRefPubMed
9.
go back to reference O’Brien S, Day C, Black E, Dolan K. Injecting drug users’ understanding of hepatitis C. Addict Behav. 2008;33:1602–1605.CrossRefPubMed O’Brien S, Day C, Black E, Dolan K. Injecting drug users’ understanding of hepatitis C. Addict Behav. 2008;33:1602–1605.CrossRefPubMed
10.
go back to reference Strauss SM, Astone-Twerell J, Munoz-Plaza CE, et al. Drug treatment program patients’ hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res. 2007;7:39.CrossRefPubMed Strauss SM, Astone-Twerell J, Munoz-Plaza CE, et al. Drug treatment program patients’ hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res. 2007;7:39.CrossRefPubMed
11.
go back to reference Beste LA, Straits-Troster K, Zickmund S, Larson M, Chapko M, Dominitz JA. Specialty care and education associated with greater disease-specific knowledge but not satisfaction with care for chronic hepatitis C. Aliment Pharmacol Ther. 2009;30:275–282.CrossRefPubMed Beste LA, Straits-Troster K, Zickmund S, Larson M, Chapko M, Dominitz JA. Specialty care and education associated with greater disease-specific knowledge but not satisfaction with care for chronic hepatitis C. Aliment Pharmacol Ther. 2009;30:275–282.CrossRefPubMed
12.
go back to reference Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94:666–668.PubMed Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94:666–668.PubMed
13.
go back to reference Doab A, Treloar C, Dore GJ. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis. 2005;40(Suppl 5):S313–S320.CrossRefPubMed Doab A, Treloar C, Dore GJ. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis. 2005;40(Suppl 5):S313–S320.CrossRefPubMed
14.
go back to reference Groessl EJ, Weingart KR, Kaplan RM, Clark JA, Gifford AL, Ho SB. Living with hepatitis C: qualitative interviews with hepatitis C-infected veterans. J Gen Intern Med. 2008;23:1959–1965.CrossRefPubMed Groessl EJ, Weingart KR, Kaplan RM, Clark JA, Gifford AL, Ho SB. Living with hepatitis C: qualitative interviews with hepatitis C-infected veterans. J Gen Intern Med. 2008;23:1959–1965.CrossRefPubMed
15.
go back to reference Ferrante JM, Winston DG, Chen PH, de la Torre AN. Family physicians’ knowledge and screening of chronic hepatitis and liver cancer. Fam Med. 2008;40:345–351.PubMed Ferrante JM, Winston DG, Chen PH, de la Torre AN. Family physicians’ knowledge and screening of chronic hepatitis and liver cancer. Fam Med. 2008;40:345–351.PubMed
16.
go back to reference Balfour L, Cooper C, Tasca GA, Kane M, Kowal J, Garber G. Evaluation of health care needs and patient satisfaction among hepatitis C patients treated at a hospital-based, viral hepatitis clinic. Can J Public Health. 2004;95:272–277.PubMed Balfour L, Cooper C, Tasca GA, Kane M, Kowal J, Garber G. Evaluation of health care needs and patient satisfaction among hepatitis C patients treated at a hospital-based, viral hepatitis clinic. Can J Public Health. 2004;95:272–277.PubMed
17.
go back to reference Gupta K, Romney D, Briggs M, Benker K. Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals. J Commun Health. 2007;32:221–230.CrossRef Gupta K, Romney D, Briggs M, Benker K. Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals. J Commun Health. 2007;32:221–230.CrossRef
Metadata
Title
Formal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable Populations
Authors
Miranda Surjadi
Cara Torruellas
Claudia Ayala
Hal F. Yee Jr.
Mandana Khalili
Publication date
01-01-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1455-3

Other articles of this Issue 1/2011

Digestive Diseases and Sciences 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.